NO173557C - Monoklonalt antistoff, immunogent konjugat, cyklosporin, fremgangsmaate for fremstilling av det monoklonale antistoff samt immunotestsett - Google Patents

Monoklonalt antistoff, immunogent konjugat, cyklosporin, fremgangsmaate for fremstilling av det monoklonale antistoff samt immunotestsett

Info

Publication number
NO173557C
NO173557C NO862177A NO862177A NO173557C NO 173557 C NO173557 C NO 173557C NO 862177 A NO862177 A NO 862177A NO 862177 A NO862177 A NO 862177A NO 173557 C NO173557 C NO 173557C
Authority
NO
Norway
Prior art keywords
monoclonal antibody
cyclosporin
producing
immunoassay kit
immunogenic conjugate
Prior art date
Application number
NO862177A
Other languages
English (en)
Norwegian (no)
Other versions
NO862177D0 (no
NO862177L (no
NO173557B (no
Inventor
Joachim Rosenthaler
Roland Wenger
Phillip E Ball
Max H Schreier
Valerie Quesniaux
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848425040A external-priority patent/GB8425040D0/en
Priority claimed from GB858515673A external-priority patent/GB8515673D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO862177D0 publication Critical patent/NO862177D0/no
Publication of NO862177L publication Critical patent/NO862177L/no
Publication of NO173557B publication Critical patent/NO173557B/no
Publication of NO173557C publication Critical patent/NO173557C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
NO862177A 1984-10-04 1986-06-02 Monoklonalt antistoff, immunogent konjugat, cyklosporin, fremgangsmaate for fremstilling av det monoklonale antistoff samt immunotestsett NO173557C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848425040A GB8425040D0 (en) 1984-10-04 1984-10-04 Organic compounds
GB858515673A GB8515673D0 (en) 1985-06-20 1985-06-20 Organic compounds
PCT/EP1985/000501 WO1986002080A1 (en) 1984-10-04 1985-09-27 Monoclonal antibodies to cyclosporings

Publications (4)

Publication Number Publication Date
NO862177D0 NO862177D0 (no) 1986-06-02
NO862177L NO862177L (no) 1986-08-04
NO173557B NO173557B (no) 1993-09-20
NO173557C true NO173557C (no) 1993-12-29

Family

ID=26288301

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862177A NO173557C (no) 1984-10-04 1986-06-02 Monoklonalt antistoff, immunogent konjugat, cyklosporin, fremgangsmaate for fremstilling av det monoklonale antistoff samt immunotestsett

Country Status (15)

Country Link
EP (4) EP0198026B1 (de)
JP (1) JPH074269B2 (de)
KR (1) KR910002691B1 (de)
AT (1) ATE92501T1 (de)
AU (4) AU589917B2 (de)
CA (1) CA1309671C (de)
CY (2) CY1915A (de)
DE (2) DE3587505T2 (de)
DK (1) DK172037B1 (de)
ES (1) ES8702949A1 (de)
FI (1) FI93965C (de)
HK (2) HK78696A (de)
NO (1) NO173557C (de)
NZ (1) NZ213680A (de)
WO (1) WO1986002080A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
EP0283801A3 (de) * 1987-03-27 1990-05-30 Abbott Laboratories Fluoreszenz-Polarisations-Test für Cyclosporin A und Metaboliten und verwandte Immunogene und Antikörper
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
WO1990006763A1 (en) * 1988-12-05 1990-06-28 The Trustees Of Columbia University In The City Of New York Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
DE69116034T2 (de) * 1990-08-15 1996-06-20 Abbott Lab Immunotestreagenzien und Verfahren zur Bestimmung von Cyclosporin
CA2055813A1 (en) * 1990-11-20 1992-05-21 Dariush Davalian Cyclosporin immunoassay
USRE40596E1 (en) * 1993-04-08 2008-12-02 Novartis Ag Rapamycin assay
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
WO1999010374A1 (en) * 1997-08-26 1999-03-04 Wisconsin Alumni Research Foundation Cyclosporin a conjugates and uses therefor
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
PT1091975E (pt) 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
AU763822B2 (en) 1998-10-09 2003-07-31 Isotechnika, Inc. Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites
RU2207870C2 (ru) * 2000-11-10 2003-07-10 Панацея Биотек Лимитед Фармацевтическая композиция, включающая циклоспорин в качестве активного ингредиента
HRP20070058B1 (hr) 2001-10-19 2014-05-23 Isotechnika Inc. Sinteza ciklosporinskih analoga
ATE535813T1 (de) 2007-05-24 2011-12-15 Abbott Lab Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
JP5542804B2 (ja) * 2008-05-23 2014-07-09 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア リポソームナノ粒子中で使用するための修飾薬物
RU2492181C2 (ru) 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012145427A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
US8906853B2 (en) 2012-11-28 2014-12-09 Enanta Pharmaceuticals, Inc. [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
HK1223843A1 (zh) 2013-08-26 2017-08-11 Enanta Pharmaceuticals, Inc. 用於預防或治療丙型肝炎的環孢菌素類似物
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
CA3000822A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
CA3020594A1 (en) 2016-04-12 2017-10-19 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
CN110506120A (zh) 2016-10-28 2019-11-26 银杏生物制品公司 用于生产化合物的组合物和方法
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
MX2022005359A (es) 2019-11-04 2022-06-02 Revolution Medicines Inc Inhibidores de ras.
CN121471132A (zh) 2019-11-04 2026-02-06 锐新医药公司 Ras抑制剂
IL301298A (en) 2020-09-15 2023-05-01 Revolution Medicines Inc Indole derivatives as RAS inhibitors in cancer therapy
IL308195A (en) 2021-05-05 2024-01-01 Revolution Medicines Inc RAS inhibitors for cancer treatment
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211526A (en) 1922-09-22 1924-02-22 John Fletcher Holliday Improvements in and relating to chain grate stokers
US4210581A (en) 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
CH614931A5 (de) * 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0098457B1 (de) 1980-02-14 1987-08-05 Sandoz Ag (1S,2R,3R)- und (1R,2S,3S)-Nitrilo-1-carbonyl-3-methyl-2-oxy-heptane und -hept-5-enen verwendbar für Totalsynthese von Cyclosporinen und Verfahren zu ihrer Herstellung
IL62965A0 (en) 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8407618D0 (en) 1984-03-23 1984-05-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
FI93965C (fi) 1995-06-26
AU4967185A (en) 1986-04-17
NZ213680A (en) 1990-05-28
EP0198026B1 (de) 1993-08-04
HK124696A (en) 1996-07-19
DE3587505D1 (de) 1993-09-09
EP0290762B1 (de) 1993-05-12
EP0314861A1 (de) 1989-05-10
DE3587505T2 (de) 1994-01-05
KR910002691B1 (ko) 1991-05-03
KR870700637A (ko) 1987-12-30
JPS62500383A (ja) 1987-02-19
ATE92501T1 (de) 1993-08-15
FI862370A0 (fi) 1986-06-03
FI93965B (fi) 1995-03-15
AU589917B2 (en) 1989-10-26
CA1309671C (en) 1992-11-03
ES8702949A1 (es) 1987-01-16
ES547495A0 (es) 1987-01-16
JPH074269B2 (ja) 1995-01-25
NO862177D0 (no) 1986-06-02
DE3587342T2 (de) 1993-12-02
CY1915A (en) 1985-09-27
CY1927A (en) 1997-05-16
DK261386A (da) 1986-06-03
HK78696A (en) 1996-05-10
AU3914389A (en) 1989-11-16
EP0198026A1 (de) 1986-10-22
FI862370A7 (fi) 1986-06-03
AU3914189A (en) 1989-11-16
NO862177L (no) 1986-08-04
EP0314862A1 (de) 1989-05-10
DK172037B1 (da) 1997-09-22
NO173557B (no) 1993-09-20
EP0290762A1 (de) 1988-11-17
AU3914289A (en) 1989-10-26
DE3587342D1 (en) 1993-06-17
DK261386D0 (da) 1986-06-03
WO1986002080A1 (en) 1986-04-10

Similar Documents

Publication Publication Date Title
NZ213680A (en) Monoclonal antibody to cyclosporin and process for its production
MY104946A (en) Antigen antibody conjugate.
DE69133095D1 (de) Cyclosporin-Immunoassay
WO1995018826A3 (en) Purified primate ctla-8 antigens and related reagents
HU9501975D0 (en) Rapamycin assay
CA2239167A1 (en) Aldolase catalytic antibody
ES2084069T3 (es) Reactivos de inmunoensayo y metodo para la determinacion de ciclosporina.
AU3066489A (en) Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
CA2097920A1 (en) Site-specific conjugation of immunoglobulins and detectable labels
CA2118010A1 (en) Antibodies specific for carcinoma-associated antigens
AU8185494A (en) Diagnostic assay for alzheimer's disease
CA2239224A1 (en) Topiramate immunoassay, as well as analogs and antibodies
EP0283801A3 (de) Fluoreszenz-Polarisations-Test für Cyclosporin A und Metaboliten und verwandte Immunogene und Antikörper
CA2113383A1 (en) Immunometric determination of an antigen or hapten
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
EP0194158A3 (de) Anti-Nikotin- und Anti-Kotinin-Antikörper (monoklonale und andere) und deren Verwendungen in Nikotin- und Kotinin-Testverfahren
CA2106563A1 (en) Cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels
CA2100586A1 (en) Htlv-i and htlv-ii peptide antigens and methods
AU2440188A (en) Immunoassays using antigens produced in heterologous organisms
IL77862A (en) Enzymatic immunoassay to determine the amount of antibodies to htlv-iii and test kit
AU1997897A (en) Nucleic acid-bound polypeptide, method of producing nucleic acid-bound polypeptide, and immunoassay using the polypeptide

Legal Events

Date Code Title Description
MK1K Patent expired